South Korea Telemedicine Market Analysis Sample Report

1. A sample report on South Korea Telemedicine Market Includes Market Size, Market Segmented by Types and Key Competitors (Data forecasts from 2022 – 2030F) www.insights10.com

2. This report presents a strategic analysis of the South Korea Telemedicine Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the South Korea Telemedicine Market, and offers unmatched value, accuracy, and expert insights

3. Report Scope Report Attribute Details Number of Pages 70-80 Base Year for Estimation 2022 Forecast Period 2023-2030 Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement Scenario Report Coverage Quantitative Units Revenue in USD Million/Billion (Mn/Bn) Research Approach Secondary Research (60%), Primary Research (40%) Click on the icon to know the detailed methodology 3 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

4. Table of Content CONTENT PG. NO. 12-25 1. Telemedicine Overview 1.1. Overview 1.2. South Korea Overview 1.3. Economic Overview: South Korea 1.4. Telemedicine Market in South Korea 1.5. Digital Health Market in South Korea 1.6. Healthcare Scenario in South Korea 1.7. Health Insurance Coverage: South Korea 1.8. Budget of the Government for Public Insurance 1.9. Mergers and Acquisitions 26-33 2. Market Size and Forecasting 2.1 Market size and forecasts (Excel and Methodology) 4 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

5. Table of Content CONTENT PG. NO. 2.2. Market Segmentation 2.2.1. Component 2.2.2. Modality 2.2.3. Application 2.2.4 Delivery Mode 2.2.5 Facility 2.2.6 End User 34-38 3. Market Dynamics 3.1. Market Growth Drivers 3.1.1. South Korea Telemedicine Market Driver 1 3.1.2. South Korea Telemedicine Market Driver 2 3.1.3. South Korea Telemedicine Market Driver 3 3.2. Market Restraints 5 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

6. Table of Content CONTENT PG. NO. 3.2.1. South Korea Telemedicine Market Restraint 1 3.2.2. South Korea Telemedicine Market Restraint 2 3.2.3. South Korea Telemedicine Market Restraint 3 39-49 4. Competitive Landscape 4.1. Major Market Share 4.2. Key Company Profile 4.2.1. K Health 4.2.1.1. Overview 4.2.1.2. Product Applications & Services 4.2.1.3. Recent Developments 4.2.1.4. Partnerships Ecosystem 4.2.1.5. Financials (Based on Availability) 6 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

7. Table of Content CONTENT PG. NO. 4.2.2. Dr. Now 4.2.2.2. Overview 4.2.2.2. Product Applications & Services 4.2.2.3. Recent Developments 4.2.2.4. Partnerships Ecosystem 4.2.2.5. Financials (Based on Availability) 4.2.3. SK Telecom Healthcare 4.2.3.1. Overview 4.2.3.2. Product Applications & Services 4.2.3.3. Recent Developments 4.2.3.4. Partnerships Ecosystem 4.2.3.5. Financials (Based on Availability) 7 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

8. Table of Content CONTENT PG. NO. 4.2.4. LG CNS Healthcare 4.2.4.2. Overview 4.2.4.2. Product Applications & Services 4.2.4.3. Recent Developments 4.2.4.4. Partnerships Ecosystem 4.2.4.5. Financials (Based on Availability) 4.2.5. Perry Health 4.2.5.1. Overview 4.2.5.2. Product Applications & Services 4.2.5.3. Recent Developments 4.2.5.4. Partnerships Ecosystem 4.2.5.5. Financials (Based on Availability) 8 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

9. Table of Content CONTENT PG. NO. 4.2.6. DoctorHere 4.2.6.1. Overview 4.2.6.2. Product Applications & Services 4.2.6.3. Recent Developments 4.2.6.4. Partnerships Ecosystem 4.2.6.5. Financials (Based on Availability) 4.2.7. Sesame Care Telemedicine 4.2.7.1. Overview 4.2.7.2. Product Applications & Services 4.2.7.3. Recent Developments 4.2.7.4. Partnerships Ecosystem 4.2.7.5. Financials (Based on Availability) 9 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

10. Table of Content CONTENT PG. NO. 4.2.8. Teladoc 4.2.8.1. Overview 4.2.8.2. Product Applications & Services 4.2.8.3. Recent Developments 4.2.8.4. Partnerships Ecosystem 4.2.8.5. Financials (Based on Availability) 4.2.9. Maven 4.2.9.1. Overview 4.2.9.2. Product Applications & Services 4.2.9.3. Recent Developments 4.2.9.4. Partnerships Ecosystem 4.2.9.5. Financials (Based on Availability) 10 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

11. Table of Content CONTENT PG. NO. 4.2.10. HealthTap 4.2.10.2. Overview 4.2.10.2. Product Applications & Services 4.2.10.3. Recent Developments 4.2.10.4. Partnerships Ecosystem 4.2.10.5. Financials (Based on Availability) 50-57 5. Reimbursement Scenario 5.1. Reimbursement Regulation 5.2. Reimbursement Process for Diagnosis 5.3. Reimbursement Process for Treatment 5.4 Reimbursement Process – Medicare 58-63 6. Methodology & Scope 11 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

12. South Korea Telemedicine Market Analysis 1. Telemedicine Overview

13. 1.1 Statistics at a Glance: The Scenario of Telemedicine in the World Scope of Telemedicine Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ 70% of the countries are expected to adopt telemedicine by 2024 52% increase in the use of telemedicine access in the APAC region In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic ▪ 147 per 1000 telemedicine visits took place post- COVID in Canada in rural areas 42% of the telemedicine, users were extremely satisfied with the service according to a survey In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 68% of the physicians reported to use the telemedicine practice according to a survey $1 to $30 Average out of pocket was paid per telemedicine visit 13 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

14. 1.1 Statistics at a Glance: The Burden of Telemedicine in the World (continued) Europe ~Revenue to reach $XX Bn by 2027 North America ~ Market Size of $XX Bn Asia -Fastest CAGR Africa South Korea Market ~$XX Mn Market ~Market Size of $XX Bn Illustrative Illustrative 14 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

15. 1.2 South Korea Overview Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic ▪ 51.7 Mn Is the population of South Korea, in 2022 $1.81 Tn Is the Gross Domestic Product (GDP) in South Korea in 2021 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 42.8 Is the median age in South Korea, in 2022 $3.9 K per capita was the amount of national health expenditures in 2021 15 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

16. 1.3 Economic Overview: South Korea Population of South Korea, (2020-2030) GDP of South Korea, (2020-2030) XX XX XX XX 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F Population Split (2023) In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic ▪ By Gender By Age Group In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 0-14 15-24 25-54 Male 49% Female 51% Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 55-64 65+ Illustrative Illustrative 16 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

17. 1.4 Statistics at a Glance: The Scenario of Telemedicine in South Korea Scope of Telemedicine Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ 31% of the doctors in reported using telemedicine services such as teleconsultations 36.61 Mn treatments were administered via telemedicine between February 2021 to February 2023 In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic in South Korea ▪ 2.88 Mn telemedicine treatments were provided to citizens aged above 60 years during the pandemic 88% of the respondents in a survey reported that they would continue treatments through telemedicine In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 17 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

18. 1.5 Digital Health in South Korea South Korea Digital Health Market Forecast, 2022-2030 (in $Bn) XX XX 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the overall Digital Health market in South Korea, which includes the market size, current trends and other details related to the topic ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 18 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

19. 1.6 Healthcare Scenario in South Korea Cancer Drug Development Process: The process of developing a cancer drug is complex and involves many stages, from preclinical research to clinical trials to regulatory approval. Here is a simplified diagram of the cancer drug development process: Preclinical Research: Researchers identify potential drug candidates and test them in the lab Phase 1 Clinical Trials: Small studies are conducted to test the safety and dosage of the drug in humans Phase 2 Clinical Trials: Larger studies are conducted to test the effectiveness of the drug in treating cancer Phase 3 Clinical Trials: Even larger studies are conducted to compare the new drug to standard treatments and evaluate its safety and effectiveness Regulatory Approval: The drug is reviewed by regulatory agencies such as the FDA and approved for use in the US market o o o o o FDA has developed several approaches to making drugs available as quickly as possible, while still ensuring their safety and effectiveness. Here are four of these approaches: Fast track is a process designed to facilitate the development, and expedite the review of drugs to treat serious conditions and fill an unmet medical need ▪ Fast Track A process designed to expedite the development and review of drugs which may demonstrate substantial improvement over available therapy Breakthrough Therapy ▪ These regulations allowed drugs for serious conditions that filled an unmet medical need to be approved based on a surrogate endpoint Accelerated Approval ▪ Priority Review A Priority Review designation means FDA’s goal is to take action on an application within 6 months ▪ Illustrative Illustrative 19 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

20. 1.6 Healthcare Scenario: Patient Journey Presentation Diagnosis Treatment Follow up Confirmatory Diagnosis Complete blood count (evaluate number & quality of RBCs, Hb & WBCs) Prevention and management of crisis: • For VOC and Splenic Sequestration: HU, Endari, Adakveo, Oxbryta • For infections: Antibiotics, Vaccines • Long term follow-up is required for patients with SCD • Annual assessment: CBC and reticulocyte count, iron status, liver and renal function tests, urinalysis, LDH, vitamin D level and neurocognitive assessment • ESOD (End Stage Organ Damage) evaluation starting from age 7 • Yearly Transcranial Doppler test to determine risk of stroke Initial Diagnosis Imaging (confirm bone related changes or respiratory problems) A suspected diagnosis is usually made, based on physical examination and detailed patient and family history Prenatal screening/ Neonatal screening Bacterial cultures of blood, sputum, urine, stool (detect any infection) Prevention and management of complications: Genetic testing (detect the type of SCD) • Stroke: Chronic transfusions, HU Stakeholders PCP, pediatrician, neonatologist, endocrinologist, cardiologist, hematologist, orthopedist, psychologist and psychiatrist PCP, paediatrician, neonatologist, haematologist and genetic counsellor PCP, pediatrician, medical geneticist, cardiologist, hematologist, endocrinologist, psychologist and psychiatrist PCP, pediatrician, medical geneticist, hematologist, gynecologist and pathologist Depending on the organ complications, the treatment involves different specialists at different times Illustrative Illustrative 20 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

21. 1.7 Health Insurance Coverage: South Korea % of People by Type of Health Insurance Coverage (2021) Number of People By Health Insurance Coverage Coverage Type 2020 2021 Change % 8.3 Uninsured Total 327,521 328,074 91.7 With health insurance Any health plan 299,230 300,887 0.4 Any private plan 217,896 216,366 –0.6 66.0 Any private plan Employment-based 178,737 178,285 –0.2 54.3 Employment-based Direct-purchase 33,869 33,555 –0.1 10.2 Direct-purchase Marketplace coverage 10,924 11,389 0.1 3.5 Marketplace TRICARE 9,165 8,299 –0.3 2.5 TRICARE Any public plan 112,925 117,095 1.2 Medicare 58,541 60,226 0.5 35.7 Any public plan 18.4 Medicare Medicaid 58,778 61,940 0.9 18.9 Medicaid VA and CHAMPVA 2,967 3,151 0.1 1.0 VA and CHAMPVA Uninsured 28,291 27,187 –0.4 In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire calendar year More people had private health insurance (66%) than public coverage (35.7%) Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%), followed by Medicaid (18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care (1%) ▪ ▪ ▪ Illustrative Illustrative 21 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

22. 1.8 Budget of South Korea Government for Public Insurance Proposed Budget By Category 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31 Outlays $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633 Medicare In Billions Of Dollars $458 $521 $571 $582 $616 $645 $674 $698 $734 $768 $801 $837 $6,926 Medicaid 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7% Medicare As % Of GDP 2.2% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.5% 2.5% 2.5% 2.5% 2.4% Medicaid National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP) ▪ Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE ▪ Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE ▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE ▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE ▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% oftotal NHE ▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020 ▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020 ▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020 ▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7% ▪ Illustrative Illustrative 22 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

23. 1.9 Mergers and Acquisitions RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend $16.7 112 110 107 107 89 82 $11.7 $10.5 $7.7 $6.8 $6.0 1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022 1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022 Buyer Composition: Strategic Vs Financial (2020) Buyer Type by Deal Size ($Mn) 39% 41% 41% 42% 58% 59% 59% 61% Strategic Buyers Financial Buyers $0- $25 $25-$50 $50-$100 $100+ 57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020 Illustrative Illustrative 23 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

24. 1.9 Mergers and Acquisitions (continued) Latest Deals In South Korea Amount / Duration Company Name Type Year Key Pointers Oracle’s acquisition of Cerner is big tech’s latest foray into the healthcare system, promising better outcomes Oracle acquire Cerner through an all-cash tender offer for $95.00 per share, or approximately $28.3 Bn in equity value Cerner is a leading provider of digital information systems used within hospitals and health systems to enable medical professionals to deliver better healthcare to individual patients and communities ▪ ▪ Acquisition $28.3 Bn June, 2022 ▪ Oracle acquisition of Cerner GSK has acquire BELLUS for US$14.75 per share of common stock in cash representing an approximate total equity value of US$2.0 billion ▪ BELLUS is a late-stage biopharmaceutical company working to better the lives of patients suffering from persistent cough ▪ Acquisition $2 Bn April 2023 Acquisition further strengthens specialty medicines and respiratory pipeline with camlipixant, a highly selective P2X3 antagonist and potential best-in-class treatment for refractory chronic cough ▪ GSK acquisition of BELLUS Health Illustrative Illustrative 24 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

25. 1.9 Mergers and Acquisitions (continued) Latest Deals In South Korea Amount / Duration Company Name Type Year Key Pointers Merger March 2023 Merger Jan 2023 Illustrative Illustrative 25 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

26. South Korea Telemedicine Market Analysis 2. Market Size and Forecasting

27. 2.1 Market size and forecasts (Excel and Methodology) Click on the icon to know the methodology and assumption South Korea Telemedicine Market Forecast, 2022-2030 (in $Bn) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ XX XX In this section you will get an understanding of the overall Healthcare Insurance market in Malaysia, which includes the market size, current trends and other details related to the topic ▪ 2022 2023F 2024F 2025F 2026F 2025 2027F 2026 2028F 2027 2029F 2030F 2023 2024 2028 2029 2030 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Major Markets Patient (Mn) 2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12 South Korea Patient Size (Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative Illustrative ▪ % of US Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45% Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937 South Korea Market Size (Bn $) 61 74 84 87 91 95 99 106 27 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

28. 2.2 Snapshot of Telemedicine Market Segmentation Component Modality Application Delivery Mode Facility End-user Store and forward Tele- Providers Products Web/Mobile Tele-hospital Radiology Tele- Audio/Text- based Payers Services Real-time Tele-home Psychiatry Patients Tele- Others Visualized Pathology Others General Consultants Call centers Others In this section you will get an understanding of the segmentations which will cover the South Korea Telemedicine Market ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 28 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

29. 2.2.1 Market Segmentation: By Component South Korea Telemedicine Market Share, By Component (2022) Products market in South Korea is a significant component of the overall telemedicine market ▪ It has the maximum market share in South Korea telemedicine market with approximately xx% ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Services Products In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 29 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

30. 2.2.2 Market Segmentation: By Modality South Korea Telemedicine Market Share, By Modality (2022) Store-forward market in South Korea is a significant component of the overall telemedicine market ▪ It has the maximum market share in South Korea telemedicine market with approximately xx% ▪ Others Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Store and forward In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Real-time 30 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

31. 2.2.3 Market Segmentation: By Application South Korea Telemedicine Market Share, By Application (2022) Tele-Radiology have the maximum market share in South Korea telemedicine market with approximately xx% ▪ Others General Consultants Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Tele-Radiology In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Tele-Pathology Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Tele-Psychiatry 31 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

32. 2.2.4 Market Segmentation: By Delivery Mode South Korea Telemedicine Market Share, By Delivery Mode (2022) Web/Mobile have the maximum market share in South Korea telemedicine market with approximately xx% ▪ Call centers Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Visualized In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Web/Mobile Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Audio/Text-based 32 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

33. 2.2.5 Market Segmentation: By Facility South Korea Telemedicine Market Share, By Facility (2022) Tele-hospital have the maximum market share in South Korea telemedicine market with approximately xx% ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Tele-home In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Tele-hospital Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 33 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

34. 2.2.6 Market Segmentation: By End-user South Korea Telemedicine Market Share, By End-user (2022) Providers have the maximum market share in South Korea telemedicine market with approximately xx% ▪ Others Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Patients Providers In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Payers 34 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

35. South Korea Telemedicine Market Analysis 3. Market Dynamics

36. 3.1 Market growth drivers 3.1.1 Incidence of cancer is increasing in South Korea, with more than 1.8 Mn new cancer cases expected to be diagnosed in 2023 Incidence of cancer is increasing in South Korea, with more than 1.8 Mn new cancer cases expected to be diagnosed in 2023 ▪ Incidence of Cancer in South Korea This is driving the demand for cancer treatments and creating opportunities for growth in the cancer market ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2010 2022 2030 Illustrative Illustrative 36 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

37. 3.1 Market growth drivers (continued) 3.1.2 Death rate from cancer in South Korea has declined by 31% from 1992 to 2022, largely due to advances in technology and treatment options Top countries that are leveraging technology in their fight against cancer South Korea has a long history of investing in cancer research and treatment, and as a result, has become a world leader in the field ▪ Norway IT has a robust healthcare infrastructure, including world- renowned research institutions, hospitals, and clinics, that are dedicated to cancer treatment and research ▪ Austria Denmark Belgium Spain One of the key factors that has allowed South Korea to stay ahead in the field of cancer research and treatment is the high level of investment in cancer-related research ▪ Italy Netherlands Sweden Singapore Switzerland In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Israel Australia Canada Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ France United Kingdom China South Korea Germany Japan United States Illustrative Illustrative 37 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

38. 3.1 Market growth drivers (continued) 3.1.3 In 2021, the National Cancer Institute (NCI) received $6.4 Bn in funding from South Korea federal government to support cancer research and training programs Fundings from government and other organizations South Korea government provides significant support and funding for cancer research and treatment, which is driving innovation and growth in the cancer market ▪ Source Year Fund ($) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ National Cancer Institute (NCI) 2021 $ 6.4 Bn In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Centers for Disease Control and Prevention (CDC) 2021 $ 501 Mn Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ American Cancer Society (ACS) 2020 $ 150 Mn Susan G. Komen 2020 $ 98 Mn Illustrative Illustrative 38 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

39. 3.2 Market restraints 3.2.1 In 2020, the average cost of a new cancer drug was over $150,000 per year 3.2.2 Average cost of developing a new cancer drug that is ultimately approved by the FDA is over $2.6 Bn 3.2.3 Demand for cancer care is expected to increase by 42% by 2025, while the supply of oncologists is only expected to increase by 28% Cancer treatments can be very expensive and can lead to financial burden for patients and healthcare systems Cost of cancer treatment varies depending on the type of cancer, stage of cancer, and treatment options Some common cancer treatments, such as chemotherapy and radiation therapy, can cost tens of thousands of dollars Regulatory requirements for cancer treatments can be very stringent, which can slow down the approval process and limit access to new treatments Regulatory bodies, such as South Korea Food and Drug Administration (FDA), require extensive clinical trials and safety data before approving new cancer treatments This can be a lengthy and costly process, which can delay the availability of new treatments for patients There is a shortage of oncologists in South Korea, which can limit access to cancer treatments and create barriers to growth in the cancer market Oncologists are physicians who specialize in the diagnosis and treatment of cancer With the aging population and the increasing incidence of cancer, there is a growing demand for oncologists However, the supply of oncologists is not keeping pace with the demand ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth. Illustrative Illustrative 39 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

40. South Korea Telemedicine Market Analysis 4. Competitive Landscape

41. 4.1 Major Market Share Revenue of Major players in South Korea Telemedicine Market ($ Mn) South Korea cancer market is a highly competitive space, with many companies developing and marketing cancer treatments ▪ Other Some of the top companies in South Korea cancer market based on revenue and market share include ▪ K Health is a Swiss multinational healthcare company that develops and markets cancer treatments, including targeted therapies and immunotherapies ▪ In 2020, K Health's oncology sales were approximately $24 Bn, making it one of the largest players in South Korea cancer market ▪ XX Illustrative Illustrative 41 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

42. 4.2 Key Company Profile Key Note: 1 K Health Here is the list of top 10 companies which will cover in the final report ▪ 2 Dr. Now Each company will have slides for ▪ 3 Overview Key details Offerings Name of products Recent activities/ Press Coverage Distribution and Vendor Partners Mergers, Acquisitions and Collaboration Financials If there are specific companies that you would like to be included in the report, please let us know via email In order to obtain access to all of the information that you are seeking, you will need to purchase the final report SK Telecom Healthcare o o 4 LG CNS Healthcare o o 5 Perry Health o 6 o DoctorHere o Sesame Care Telemedicine 7 o 8 Teladoc ▪ 9 Maven ▪ 10 HealthTap 42 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

43. 4.2.1 K Health Services offered by K Health ▪ K Health is a clinical primary care firm with a mission to provide everyone with high-quality healthcare on a large scale ▪ K Health also provides text-based treatment from doctors practicing on its platform for less than a copay, with no insurance required, through associated professional organizations ▪ K Health provides remote wellness consultations, customized treatment plans, weight loss management, and mail-order medicines in addition to treating hundreds of urgent and chronic ailments, as well as anxiety and depression Founded in: 2016 ➢ Primary Care HQ: New York, US ➢ Weight Management Type: Private ➢ Urgent Care Revenue: $23.1 Mn ➢ Mental Health Website: www.khealth.com ➢ Pediatrics Recent Activity / Press Coverage K Health, a digital health unicorn, collaborated with the Mayo Clinic to create an artificial intelligence diagnosis model that will assist clinicians in swiftly identifying better hypertension medications for their patients K Health ranks 10thin the Top 10 Most Innovative Companies of 2022 With the purchase of Trusst, a behavioral health software that gives users with access to online, text-based treatment, K Health, a virtual data-driven primary care platform, intends to expand its services to the mental health area 43 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

44. 4.2.1 K Health (continued) Partnerships Ecosystem Major Distribution Partners Major Vendor Partners One of the largest pharmaceutical distributors in the United States, McKesson has been a long-standing distribution partner for K Health K Health has been working with SAP, a leading software company, to develop digital solutions for its healthcare products A leading Swiss biotechnology company, Lonza provides K Health with contract manufacturing services for the production of its biologics and pharmaceuticals Cardinal Health is a Fortune 500 healthcare services company that provides pharmaceutical distribution services to K Health It is one of the largest drugstore chains in the United States and Europe, and its extensive network of retail locations and distribution centers make it an important distribution partner for K Health K Health has a strategic partnership with Microsoft to leverage its cloud computing and AI technologies in the development of new healthcare products Thermo Fisher Scientific is a leading provider of analytical instruments, reagents, and laboratory services A leading healthcare services provider in Asia, Zuellig Pharma is a distribution partner for K Health in several Asian countries GE Healthcare provides K Health with advanced medical imaging and diagnostics technologies, including CT scanners and MRI machines Illustrative Illustrative One of the largest pharmaceutical wholesalers in Europe, PHOENIX Group distributes K Health's products in several European countries 44 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

45. 4.2.1 K Health (continued) Latest Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers K Health created a tailored hypertension therapy algorithm that makes use of de-identified Mayo Clinic data to assist shorten the time between diagnosis and treatment Demographics, medical history, blood findings, drugs taken, and outcomes are among the data points Model will be made available to K Health's doctor network and its more than 6 million customers ▪ Collaboration ▪ - June, 2022 Mayo Clinic ▪ K Health to acquire GenMark Diagnostics for US$ 24.05 per share with the expectation to close in the 2nd quarter of 2021 ▪ GenMark provides molecular diagnostic tests that are designed to detect multiple pathogens from a single patient sample ▪ Merger $1.8 Bn March 2021 GenMark Diagnostics GenMark’s ePlex platform delivers rapid and actionable results so clinicians can determine the cause of infection and the most effective treatment, potentially saving lives and alleviating the healthcare burden ▪ Illustrative Illustrative 45 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

46. 4.2.1 K Health (continued) Revenues ($Bn), 2020-2030 According to K Health's 2020 financial report, the company had sales of CHF 58.3 Bn (Swiss Francs) in 2020 ▪ This is equivalent to approximately $63.3 Bn USD, based on exchange rates at the end of 2020 ▪ XX Company's Pharmaceuticals Division generated sales of CHF 49.9 Bn in 2020, while the Diagnostics Division generated sales of CHF 8.4 Bn ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Breakdown of Net Revenue by Segment, 2022 Revenue generated by K Health in 2020 reflects the company's continued growth and success in the healthcare industry ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 1 2 3 4 Illustrative Illustrative 46 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

47. 4.2.2 Company 2 Solutions offered by Company Founded in: HQ: Type: Revenue: Website: Drugs for Cancer Recent Activity / Press Coverage Drugs Indications Illustrative Illustrative 47 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

48. 4.2.2 Company 2 (continued) Partnerships Ecosystem Major Distribution Partners Major Vendor Partners Illustrative Illustrative 48 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

49. 4.2.2 Company 2 (continued) Latest Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers Illustrative Illustrative 49 A Sample Report on South Korea Telemedicine Market Analysis I Confidential

50. 4.2.2 Company 2 (continued) Revenues ($Bn), 2020-2030 Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ xx xx xx In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Breakdown of Net Revenue by Segment, 2022 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 1 2 3 4 Illustrative Illustrative 50 A Sample Report on South Korea Telemedicine Market Analysis I Confidential